SBRI: Clinical biomarker tools and technologies for dementia

Organisations can apply for a share of £6 million, inclusive of VAT, to develop or repurpose platform technologies. These technologies can be used as clinical tools to enable the bio-marker guided development of transformative dementia therapies.

This is a Small Business Research Initiative (SBRI) competition funded by Innovate UK.

The aim of the competition is to accelerate innovations in dementia biomarker detection to transform clinical trials and precision therapies.

This will be achieved by the development of or repurposing of technologies that will enable the robust detection of emerging dementia clinical biomarkers. The application of innovations in wet biomarkers, data, and tools and services, will feed into and support the aims of the UK government’s Dame Barbara Windsor dementia mission.